TNF promoter -308 G>A and LTA 252 A>G polymorphisms in Portuguese patients with systemic lupus erythematosus

Rheumatology International

Volumn 32, Issue 8, 2012, Pages 2239-2244

  Santos, Maria José ^a,c   Carmona Fernandes, Diana ^a   Caetano Lopes, Joana ^a   Perpétuo, Inês P ^a   Vidal, Bruno ^a   Capela, Susana ^b   Da Silva, José Canas ^c   Fonseca, João Eurico ^b  

^a INSTITUTO DE MEDICINA MOLECULAR JOÃO LOBO ANTUNES   (Portugal)

^b HOSPITAL DE SANTA MARIA   (Portugal)

^c HOSPITAL GARCIA DE ORTA   (Portugal)

Author keywords

308 TNF G>A; Genetics; LTA 252 A>G; Nephritis; Systemic lupus erythematosus

Indexed keywords

LYMPHOTOXIN; TUMOR NECROSIS FACTOR;

ADULT; ARTICLE; CAUCASIAN; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; LTA GENE; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PORTUGAL; PRIORITY JOURNAL; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMIC LUPUS ERYTHEMATOSUS; TNF GENE;

ADULT; AUTOANTIBODIES; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; LYMPHOTOXIN-ALPHA; MALE; MIDDLE AGED; ODDS RATIO; PHENOTYPE; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PORTUGAL; PREVALENCE; PROMOTER REGIONS, GENETIC; RISK ASSESSMENT; RISK FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84866254974     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-011-1950-7     Document Type: Article

References (29)

1. Sestak AL, Nath SK, Sawalha AH, Harley JB (2007) Current status of lupus genetics. Arthritis Res Ther 9:210
2. Tsao BP, Grossman JM (2001) Genetics and systemic lupus erythematosus. Curr Rheumatol Rep 3:183-190
3. Gabay C, Cakir N, Moral F, Roux-Lombard P, Meyer O, Dayer JM et al (1997) Circulating levels of tumor necrosis factor soluble receptors in systemic lupus erythematosus are significantly higher than in other rheumatic diseases and correlate with disease activity. J Rheumatol 24:303-308
4. Zhu L, Yang X, Ji Y, Chen W, Guan W, Zhou SF et al (2009) Up-regulated renal expression of TNF-alpha signaling adapter proteins in lupus glomerulonephritis. Lupus 18:116-127
5. Aringer M, Graninger WB, Steiner G, Smolen JS (2004) Safety and efficacy of tumor necrosis factor alpha blockade in systemic lupus erythematosus: an open-label study. Arthritis Rheum 50:3161-3169
6. Matsumura R, Umemiya K, Sugiyama T, Sueishi M, Umibe T, Ichikawa K et al (2009) Anti-tumor necrosis factor therapy in patients with difficult-to-treat lupus nephritis: a prospective series of nine patients. Clin Exp Rheumatol 27:416-421
7. Ramos-Casals M, Brito-Zerón P, Muñoz S, Soria N, Galiana D, Bertolaccini L et al (2007) Autoimmune diseases induced by TNF-targeted therapies: analysis of 233 cases. Medicine (Baltimore) 86:242-251
8. Körner H, Sedgwick JD (1996) Tumour necrosis factor and lymphotoxin: molecular aspects and role in tissue-specific autoimmunity. Immunol Cell Biol 74:465-472
9. Karimi M, Goldie LC, Cruickshank MN, Moses EK, Abraham LJ (2009) A critical assessment of the factors affecting reporter gene assays for promoter SNP function: a reassessment of -308 TNF polymorphism function using a novel integrated reporter system. Eur J Hum Genet 17:1454-1462
10. Lee YH, Harley JB, Nath SK (2006) Meta-analysis of TNF-alpha promoter -308 A/G polymorphism and SLE susceptibility. Eur J Hum Genet 14:364-371
11. Bettinotti MP, Hartung K, Deicher H, Messer G, Keller E, Weiss EH, Albert ED (1993) Polymorphism of the tumor necrosis factor beta gene in systemic lupus erythematosus: TNFB-MHC haplotypes. Immunogenetics 37:449-454
12. Kim HY, Lee SH, Yang HI, Park SH, Cho CS, Kim TG et al (1995) TNFB gene polymorphism in patients with systemic lupus erythematosus in Korean. Korean J Intern Med 10:130-136
13. *2/2 genotype, but not the TNFa, b microsatellite alleles, to systemic lupus erythematosus in Japanese patients. J Immunogenet 32:173-178
14. Zhang J, Ai R, Chow F (1997) The polymorphisms of HLA-DR and TNF B loci in northern Chinese Han nationality and susceptibility to systemic lupus erythematosus. Chin Med Sci J 12:107-110
15. Parks CG, Pandey JP, Dooley MA, Treadwell EL, St Clair EW, Gilkeson GS et al (2004) Genetic polymorphisms in tumor necrosis factor (TNF)-alpha and TNF-beta in a population-based study of systemic lupus erythematosus: associations and interaction with the interleukin-1alpha-889 C/T polymorphism. Hum Immunol 65:622-631
16. Hochberg MC (1997) Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725
17. Gladman DD, Ibañez D, Urowitz MB (2000) Systemic lupus erythematosus disease activity index 2000. J Rheumatol 29:288-291
18. Gladman D, Ginzler E, Goldsmith C, Fortin P, Liang M, Urowitz M et al (1996) The development and initial validation of the systemic lupus international collaborating clinics/American college of rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 39:363-369
19. Fugger L, Morling N, Ryder LP, Georgsen J, Jakobsen BK, Svejgaard A et al (1989) NcoI restriction fragment length polymorphism (RFLP) of the tumor necrosis factor (TNF alpha) region in four autoimmune diseases. Tissue Antigens 34:17-22
20. Rudwaleit M, Tikly M, Khamashta M, Gibson K, Klinke J, Hughes G et al (1996) Interethnic differences in the association of tumor necrosis factor promoter polymorphisms with systemic lupus erythematosus. J Rheumatol 23:1725-1728
21. Zúñiga J, Vargas-Alarcón G, Hernández-Pacheco G, Portal-Celhay C, Yamamoto-Furusho JK, Granados J (2001) Tumor necrosis factor-alpha promoter polymorphisms in Mexican patients with systemic lupus erythematosus (SLE). Genes Immun 2:363-366
22. D'Alfonso S, Colombo G, Della Bella S, Scorza R, Momigliano-Richiardi P (1996) Association between polymorphisms in the TNF region and systemic lupus erythematosus in the Italian population. Tissue Antigens 47:551-555
23. Wilson AG, de Vries N, Pociot F, di Giovine FS, van der Putte LB, Duff GW (1993) An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA A1, B8, and DR3 alleles. J Exp Med 177:557-560
24. Rood MJ, van Krugten MV, Zanelli E, van der Linden MW, Keijsers V, Schreuder GM et al (2000) TNF-308A and HLA-DR3 alleles contribute independently to susceptibility to systemic lupus erythematosus. Arthritis Rheum 43:129-134
25. Vasconcelos C, Carvalho C, Leal B, Pereira C, Bettencourt A, Costa PP et al (2009) HLA in Portuguese systemic lupus erythematosus patients and their relation to clinical features. Ann N Y Acad Sci 1173:575-580
26. Fonseca JE, Cavaleiro J, Teles J, Sousa E, Andreozzi VL, Antunes M et al (2007) Contribution for new genetic markers of rheumatoid arthritis activity and severity: sequencing of the tumor necrosis factor-alpha gene promoter. Arthritis Res Ther 9:R37
27. Mourão AF, Caetano-Lopes J, Costa P, Canhão H, Santos MJ, Pinto P et al (2009) Tumor necrosis factor-alpha -308 genotypes influence inflammatory activity and TNF-alpha serum concentrations in children with juvenile idiopathic arthritis. J Rheumatol 36:837-842
28. Sousa E, Caetano-Lopes J, Pinto P, Pimentel F, Teles J, Canhão H et al (2009) Ankylosing spondylitis susceptibility and severity-contribution of TNF gene promoter polymorphisms at positions - 238 and -308. Ann N Y Acad Sci 1173:581-588
29. Panoulas VF, Nikas SN, Smith JP, Douglas KM, Nightingale P, Milionis HJ et al (2008) Lymphotoxin 252A>G polymorphism is common and associates with myocardial infarction in patients with rheumatoid arthritis. Ann Rheum Dis 67:1550-1556